Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NewSelf vs Revel RX

By GLP-1 ScorecardUpdated

NewSelfFactor scores not reassessed.
Site position #38

Higher score

Revel RXFactor scores not reassessed.
Site position #48

Lower score

Score comparison

NewSelf has the higher recorded score — 79.8/100 to 77.3/100.

NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NewSelf advertises flat pricing across doses, but its refund policy requires a three-month commitment even on a monthly payment plan.

Before you choose

Before comparing the headline prices, the NewSelf review and the Revel RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, NewSelf vs RxPros and OrderlyMeds vs Revel RX compare each of them with another graded program, and the list of alternatives to NewSelf ranks the programs closest to NewSelf on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Peter MD review covers one graded close to these two, at 78.1/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRevel RX +3
93
96
Dose & formulationNewSelf +8
80
72
Clinical oversightRevel RX +29
55
84
Labs & monitoringNewSelf +29
82
53
FulfillmentNewSelf +6
87
81
Contract termsNewSelf +30
85
55
NewSelf · top barRevel RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricNewSelfRevel RX
WeighScore79.8/10077.3/100
GradeC+C+
Site position#38#48
SemaglutideFrom $99.97/mo with a three-month commitment; confirm upfront charge and renewal$89/mo (advertised all doses, compounded)
TirzepatideFrom $144.49/mo with a three-month commitment; confirm upfront charge and renewal$155/mo (advertised all doses, compounded)
CoverageAdvertises access in all 50 statesCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
NewSelf

Site position #38 · C+

Factor scores not reassessed.

FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.

Strengths

  • Separate starting prices for both medications
  • Advertises no membership fee or dose surcharge

What to consider

  • Monthly payments do not shorten the three-month commitment
  • An eligible pre-consult refund is reduced by a $99 administrative fee
  • The policy generally excludes refunds after the consultation and describes an early cancellation fee
Revel RX

Site position #48 · C+

Factor scores not reassessed.

Strengths

  • Publishes prices for both compounded medications
  • Advertises clinician review and included shipping
  • Provides written instructions for canceling before shipment

What to consider

  • The refund policy treats charged orders already handed to the carrier as final
  • No dispensing pharmacy assignment or state eligibility was verified for an individual order

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard